The Parkinson Pandemic

March 19, 2025Tolhuistuin (Club) Amsterdam
Scienceandcocktails parkinson brain scan sci fi 4 K d390a66f c77c 4654 b948 fa49fef07e13
Doors open: 19:00
Start programme: 19:45
Tolhuistuin (Club)
IJpromenade 2
Amsterdam

Parkinson’s disease is the world’s fastest-growing neurodegenerative disorder, and this trend is deeply concerning for two reasons. First, it is a debilitating condition that severely impacts both individuals and their families. Disease progression is relentless, with no known cure or disease-modifying treatments. While symptomatic therapies exist, they provide only limited relief, and quality of life remains significantly affected.

Second, growing evidence suggests that Parkinson’s is, to a large extent, a man-made disease. The global rise in cases is largely driven by exposure to environmental chemicals, making Parkinson’s a potentially preventable condition. In his talk, Professor Bas Bloem will examine the compelling evidence linking ecological factors (such as pesticides) to the onset of Parkinson’s disease. He will also highlight the gaps in current regulations that leave the safety of many widely used chemicals uncertain.

Despite these challenges, there is hope. Bloem will discuss emerging treatment strategies aimed at slowing disease progression and improving patient support. At the Radboudumc Centre of Expertise for Parkinson & Movement Disorders, researchers are pioneering a holistic approach to care, ensuring that individuals with Parkinson’s and their families receive optimal support.

This event is an initiative by the Dutch Institute for Emergent Phenomena (DIEP) with the support of the University of Amsterdam. Science & Cocktails Amsterdam is presented in cooperation with Paradiso Amsterdam.

Programme

  • 19:00–   19:45
    Doors open for cocktails
  • 19:45–   20:30
    Band (TBA)
  • 20:30–   22:00
    Bas Bloem

Talk by

Bas Bloem

Professor Bas Bloem is a consultant neurologist at the Department of Neurology at Radboud University Medical Centre in Nijmegen. He earned his medical degree and PhD before training as a neurologist at Leiden University Medical Centre. He further specialized in movement disorders through fellowships at The Parkinson’s Institute (California) and the Institute of Neurology (London). In September 2008, he was appointed Professor of Neurology, focusing on movement disorders.Bloem serves on the editorial boards of several national and international journals, including as co-editor-in-chief of the Journal of Parkinson’s Disease. He has authored over 1,000 publications and is regarded as one of the world’s leading experts in Parkinson’s disease.

His contributions have earned him numerous awards, including the Stevin Prize, the highest recognition for a Dutch scientist whose work has profoundly impacted society. In April 2024, he was appointed Knight in the Order of the Dutch Lion, the highest royal distinction in the Netherlands. In 2002, Bloem founded and became director of the Radboudumc Centre of Expertise for Parkinson & Movement Disorders, which has been recognized as a center of excellence since 2005. Together with Dr. Marten Munneke, he co-developed ParkinsonNet, an innovative healthcare model that now consists of 70 professional networks supporting individuals with Parkinson’s across the Netherlands.

Annemarijne Bax Hemelbestormer Bas Bloem